XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation Expense and Shareholders' Equity (Tables)
 6 Months Ended
Jan. 31, 2022
Stockholders' Equity and Stock-based Compensation [Abstract]  
Stock-based compensation expense
Stock-based compensation expense related to stock options and Stock Awards is included in the Company’s condensed consolidated statements of operations as follows (in thousands):

Three Months Ended January 31,Six Months Ended January 31,
2022202120222021
Stock-based compensation expense$38,147 $30,209 $70,680 $58,603 
Net impact of deferred stock-based compensation(282)(313)(575)(623)
 Total stock-based compensation expense, net$37,865 $29,896 $70,105 $57,980 
Stock-based compensation expense is included in the following categories:
Cost of subscription and support revenue$3,773 $2,954 $7,121 $5,556 
Cost of license revenue189 145 371 396 
Cost of services revenue6,081 5,578 11,718 11,121 
Research and development9,433 7,604 18,047 14,851 
Sales and marketing10,825 6,806 18,314 12,783 
General and administrative7,564 6,809 14,534 13,273 
Total stock-based compensation expense$37,865 $29,896 $70,105 $57,980 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of the Company’s Stock Awards activity under the Company’s equity incentive plans is as follows:

 Stock Awards Outstanding
 Number of Stock Awards Outstanding Weighted Average Grant Date Fair Value
 Aggregate Intrinsic Value (in thousands)(1)
Balance as of July 31, 20212,394,968 $107.15 $275,900 
Granted1,609,375 $119.61 
Released(665,640)$104.90 $76,912 
Canceled(203,385)$110.53 
Balance as of January 31, 20223,135,318 $113.80 $316,165 
Expected to vest as of January 31, 20223,135,318 $113.80 $316,165 
(1) Aggregate intrinsic value at each period end represents the total market value of Stock Awards at the Company’s closing stock price of $100.84 and $115.20 on January 31, 2022 and July 31, 2021, respectively. Aggregate intrinsic value for released Stock Awards represents the total market value of released Stock Awards at date of release.
Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity under the Company’s equity incentive plans is as follows:

 Stock Options Outstanding
 Number of Stock Options Outstanding Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
 Aggregate Intrinsic Value(1)
(in years) (in thousands)
Balance as of July 31, 202125,278 $17.39 5.0$2,472 
Granted— 
Exercised(8,748)$11.12 $900 
Canceled— 
Balance at January 31, 202216,530 $20.72 3.7$1,324 
Vested and expected to vest as of January 31, 202216,530 $20.72 3.7$1,324 
Exercisable as of January 31, 202216,530 $20.72 3.7$1,324 
(1) Aggregate intrinsic value at each period end represents the difference between the Company’s closing stock price of $100.84 and $115.20 on January 31, 2022 and July 31, 2021, respectively, and the exercise price of outstanding options. Aggregate intrinsic value for exercised options represents the difference between the Company’s stock price at date of exercise and the exercise price.
Common Stock Reserved for Issuance
As of January 31, 2022 and July 31, 2021, the Company had reserved shares of common stock for future issuance as follows:

January 31, 2022July 31, 2021
Exercise of stock options to purchase common stock16,530 25,278 
Vesting of stock awards3,135,318 2,394,968 
Shares available under stock plans3,608,079 5,014,069 
Total common stock reserved for issuance6,759,927 7,434,315